High Precision Bioassay Using Robotics and Statistics
High Precision Bioassay Using Robotics and Statistics
批准号:
7613835
负责人:
David Matthew Lansky
金额:
$2.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-15 至 2012-02-28
关键词:
AccountingAddressAnimal WelfareAppendixAttentionBibliographyBiological AssayBiotechnologyConsultCountryCultured CellsData CompromisingDevelopmentEnvironmentEnvironmental ImpactEquipmentIACUCIndustryInternationalLaboratoriesLansky Play-Performance StatusLocationMeasuresNamesNumbersOther ResourcesPrincipal InvestigatorProteinsRandomizedResearchResearch Ethics CommitteesRobotRoboticsSourceVaccinesVariantVertebratesWorkabstractingassay developmentexpirationhuman subjectprogramsresponsestatistics
中文摘要
项目总结
英文摘要
Project Summary
Abstract
Cell culture bioassays are often laborious and imprecise even after substantial
development efforts. These bioassays are used broadly in the biotechnology industry to
measure protein or vaccine products in development and for lot release. Imprecise
assays and slow assay development contribute to slow product development. Common
practice in cell culture bioassay ignores statistical and regulatory guidance by failing to
utilize proper randomization and not accounting for group effects (i.e.; as caused by
multi-channel pipettes). In addition, lack of attention to location effects within the assays,
combined with simplistic analyses of assay data, compromise the precision and
efficiency of cell culture bioassays.
Lansky Consulting LLC will develop a standardized approach to cell culture bioassay
using laboratory robots followed by modern statistical analysis. This combination will
address the need for randomization, location effects, serial dilution, grouped dilution, and
multiple sources of variation in assay response. The work described in this proposal will
demonstrate the performance gains associated with:
1) standardized designs (including designs that require robots for randomization),
2) linear and nonlinear mixed split- or strip-plot models for bioassay analysis, and
3) advances in implementation of this modern standardized approach to bioassays.
The precision gains from the combined package of modern bioassay methods will be
shown to reduce the need for sample replication by an order of magnitude or more. Both
simulated data and long-term lab experiments with bioassays will be used. The benefits
of these new methods include lower assay costs, rapid application to new assay
systems, and easy access to best practices in design, implementation, and analysis.
Most importantly, by building a turnkey robotic and analysis bioassay system, this level
of assay performance will be made broadly available to the biotechnology industry as
well as to non-profit researchers.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1089/jir.2008.0043
发表时间:
2009
期刊:
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
影响因子:
--
作者:
[Grossberg,SidneyE, Kawade,Yoshimi, Grossberg,LeslieD]
通讯作者:
Grossberg,LeslieD
Better bioassays via designs for robots analyses with improved model selection and similarity bounds that limit potency bias
-
批准号:10155988
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2021
-
负责人:David Matthew Lansky
-
依托单位:
High Precision Bioassay Using Robotics and Statistics
-
批准号:7221731
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2005
-
负责人:David Matthew Lansky
-
依托单位:
High Precision Bioassay Using Robotics and Statistics
-
批准号:6882967
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2005
-
负责人:David Matthew Lansky
-
依托单位:
High Precision Bioassay Using Robotics and Statistics
-
批准号:7371144
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2005
-
负责人:David Matthew Lansky
-
依托单位:
海外基金